Intercalated Duct Cells are specialized epithelial cells integral to the structure and function of exocrine glands, particularly in the salivary glands and pancreas. These cells play a pivotal role in the modification of fluid secretions, contributing to the production of enzymes and maintaining the appropriate composition of various exocrine gland secretions. In the salivary glands, intercalated duct cells are responsible for adjusting the electrolyte concentration and pH of saliva, facilitating its role in digestion. Similarly, in the pancreas, these cells contribute to the modification of pancreatic juice, ensuring optimal conditions for enzyme activity in the small intestine. Intercalated duct cells achieve these functions through the selective transport of ions and water across their membranes. The modifications introduced by these cells transform the primary secretions from acinar or centroacinar cells into the final, functional secretions that contribute to digestive processes. Disruptions in the function of intercalated duct cells can lead to imbalances in glandular secretions, affecting overall digestive function. Understanding the intricate role of intercalated duct cells is essential for comprehending exocrine gland physiology and can have implications for the diagnosis and treatment of disorders related to these vital digestive organs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States